Blackstone and TPG Acquire Hologic in $18.3 Billion Deal
On October 20, TPG and Blackstone announced that they entered into a definitive agreement to acquire Hologic, Inc. The purchase represents an enterprise value of up to $18.3 billion. Founded in 1985, Hologic develops, manufactures and sells premium diagnostic products, medical imaging systems and surgical products, primarily for women’s health. Hologic reported an annual revenue of more than $4 billion for its 2024 fiscal year, which ended on September 28, 2024. TPG is a global alternative asset management firm. It was founded in San Francisco in 1992 and has $246 billion of assets under management. Blackstone is the world’s largest alternative asset manager. The... Read More »
Avanos Medical Bolsters Device Portfolio With Nexus Medical
On September 15, Avanos Medical, Inc. announced the acquisition of Nexus Medical, LLC for an undisclosed price. Nexus Medical is a Lenexa, Kansas-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. Nexus is renowned for its TKO anti-reflux needleless connector technology, which enhances the safety and consistency of nutrition and medication delivery, particularly in high-acuity settings like neonatal and pediatric intensive care units. Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device... Read More »
Keensight Capital Acquires Majority Stake in Isto Biologics
French private equity firm Keensight Capital announced it has agreed to acquire a majority stake in Isto Biologics from Thompson Street Capital Partners. Founded in 2016, Isto Biologics is a regenerative MedTech company developing and manufacturing orthobiologic products to help patients heal faster. Isto’s product offering covers six functional areas of unique bone graft solutions, and includes a range of allografts, which are notably used for bone repair in the spine. Isto sells its products to more than 400 hospitals and clinics, which are used in 15,000 surgical procedures per month, primarily in the United States. Keensight Capital is a European growth buyout firm. With more than 25... Read More »
Alcon to Acquire STAAR Surgical Company
According to an August 5 announcement, Alcon has entered into a definitive merger agreement to acquire STAAR Surgical Company. The transaction represents a total equity value of approximately $1.5 billion. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. According to its most recent annual report, STAAR generated $313.9 million in revenue during the fiscal year 2024 and had an EBITDA loss of $8 million. Alcon, a division of Novartis, researches and develops products for eye conditions such as cataracts, glaucoma, retinal diseases and refractive... Read More »
